BTIG Keeps Anavex Life Sciences (AVXL) PT at $35, Says 'Data Incomplete But Still Sufficient To Support A Pathway Forward'
Tweet Send to a Friend
(Updated - December 2, 2022 8:16 AM EST)
BTIG analyst Yun Zhong reiterated a Buy rating and $35.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Yun Zhong reiterated a Buy rating and $35.00 price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
